Seer to Present at the Morgan Stanley Global Healthcare Conference
September 02 2021 - 4:05PM
Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing
a disruptive new platform for proteomics, today announced it will
be participating virtually in the upcoming Morgan Stanley Global
Healthcare Conference.
Seer’s management is scheduled to participate in
a fireside chat on Thursday, September 9 at 9:30 a.m. Pacific Time
/ 12:30 p.m. Eastern Time. A live webcast of the virtual session
will be available on the Investor section of Seer’s website at
investor.seer.bio. An archived replay will be available on the
company’s website following the conference.
About SeerSeer is a life
sciences company developing transformative products that open up a
new gateway to the proteome. Seer is commercializing its
Proteograph Product Suite, an integrated solution that includes
proprietary engineered nanoparticles, consumables, automation
instrumentation and software to perform deep, unbiased proteomic
analysis at scale in a matter of hours. Seer designed the
Proteograph workflow to be efficient and easy-to-use, leveraging
widely adopted laboratory instrumentation to provide a
decentralized solution that can be adopted by nearly any
lab. Seer’s Proteograph Product Suite is for research use only
and is not intended for diagnostic procedures. For more
information, please visit www.seer.bio.
Investor ContactCarrie
Mendivilinvestor@seer.bio
Media ContactKaren Possematopr@seer.bio
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jun 2024 to Jul 2024
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jul 2023 to Jul 2024